Please assess the completion status of the following clinical trial:

Trial Title: Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meet the 1984 Modified New York Criteria for Classification of Ankylosing Spondylitis~* With axial involvement~* Without peripheral joint involvement (synovitis) at the time of study entry, (excluding involvement of the hips, knees and shoulders)~* Need for daily treatment with NSAIDs during the previous 30 days before study entry~Exclusion Criteria:~* Known inflammatory enteropathy (eg, ulcerative colitis, Crohn's disease, etc)~* Presence of extra-articular manifestations (eg, uveitis, endocarditis, etc.)~* Known vertebral compression~* Need for a corset during the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Celecoxib 200 mg QD (Type: EXPERIMENTAL): None
- Diclofenac SR 75 mg QD (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).